Drug Eluting Beads Market
Drug Eluting Beads Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Drug Eluting Beads Market Size and Growth
The Drug Eluting Beads (DEB) market is experiencing robust growth, driven by increasing cancer prevalence and advancements in interventional oncology. The global market size is estimated to reach approximately $900 million by 2027, reflecting a CAGR of around 10%. Competitive innovations and regulatory approvals are shaping market dynamics positively. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Biocompatibles
◍ BTG International
◍ Merit Medical Systems
◍ CeloNova BioSciences
◍ ABK Biomedical
◍ Boston Scientific
◍ Medtronic
◍ Merit Medical Systems
◍ Surefire Medical
◍ Terumo
The Drug Eluting Beads Market features players like Biocompatibles, BTG International, Merit Medical Systems, and Boston Scientific. These companies innovate with advanced drug delivery systems, enhancing treatment efficacy. Their contributions, such as new product launches and strategic partnerships, drive market growth. Notable sales include BTG's revenue of $810 million.
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Specialized Clinics
◍ Research Centers
◍ Ambulatory Surgical Centers
By Product
◍ Oncozene Beads ◍ Quadra Sphere ◍ LC Beads ◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
